CORRIGAN MARK 4
4 · Nabriva Therapeutics plc · Filed May 4, 2018
Insider Transaction Report
Form 4
CORRIGAN MARK
Director
Transactions
- Award
Stock Option
2018-05-02+29,000→ 29,000 totalExp: 2028-05-02→ Ordinary Shares (29,000 underlying)
Footnotes (2)
- [F1]The exercise price is $4.91 per share.
- [F2]This option was granted on May 2, 2018. Vesting began on May 2, 2018 and ends on May 2, 2019. One hundred percent (100%) of the option will vest on May 2, 2019.